Chemed (NYSE:CHE) PT Raised to $604.00

Chemed (NYSE:CHE – Free Report) had its target price increased by Royal Bank of Canada from $576.00 to $604.00 in a report published on Monday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. Separately, StockNews.com initiated coverage on Chemed in a research note on Thursday, October 5th. They […]

Leave a Reply

Your email address will not be published.

Previous post Piper Sandler Cuts First Interstate BancSystem (NASDAQ:FIBK) Price Target to $32.00
Next post Brad Stevens’ basketball journey was shaped by late Bob Knight: ‘He was bigger than life’